
PRISMA 2020 FLOW DIAGRAM - SYSTEMATIC REVIEW STUDY SELECTION
============================================================

IDENTIFICATION:
├─ Records identified through database searching (n = 462)
│  ├─ PubMed, Web of Science, Embase
│  ├─ IEEE Xplore, ACM Digital Library, Scopus  
│  └─ arXiv, bioRxiv, medRxiv
├─ Additional records through manual curation
│  ├─ High-impact journal screening
│  └─ Preprint repository monitoring
└─ Total records before screening (n = 462)

SCREENING:
├─ Records screened (title/abstract) (n = 462)
│  ├─ Two independent reviewers
│  ├─ Inter-rater agreement (κ = 0.876)
│  │  ├─ Interpretation: Almost perfect agreement
│  │  ├─ Percentage agreement: 96.3%
│  │  ├─ Disagreement rate: 3.7%
│  │  └─ Quality threshold (≥0.60): ✓ Met
│  └─ Conflict resolution via discussion
├─ Records excluded (n = 60)
│  ├─ Duplicate methodologies (n = 10)
│  ├─ Insufficient deep learning incorporation (n = 10)  
│  ├─ Preliminary results lacking validation (n = 8)
│  ├─ No spatial resolution/bulk omics only (n = 7)
│  ├─ Non-cardiac tissue focus (n = 6)
│  ├─ Insufficient methodological detail (n = 6)
│  ├─ Small sample sizes (n = 4)
│  ├─ Purely theoretical frameworks (n = 4)
│  └─ Other exclusion reasons (n = 5)
└─ Records eligible for full-text retrieval (n = 402)

ELIGIBILITY:
├─ Full-text articles assessed for eligibility (n = 402)
├─ Full-text articles excluded (n = 314)
│  ├─ Not directly addressing cardiomyocyte differentiation 
│  │   or cardiac regeneration (n = 95)
│  ├─ Methodological overlap/redundancy with higher
│  │   quality publications (n = 85)
│  ├─ Absence of technical reproducibility or detailed
│  │   methodological descriptions (n = 60)
│  ├─ Restriction to bulk transcriptomics/non-spatial
│  │   omics approaches (n = 45)
│  └─ Failure to meet spatial multi-omics integration
│      criterion (n = 29)
└─ Studies meeting inclusion criteria (n = 88)

INCLUDED:
└─ Studies included in qualitative synthesis (n = 88)
   ├─ Comprehensive data extraction performed
   ├─ Quality assessment completed
   └─ Synthesis focused on:
      ├─ Study design parameters
      ├─ Specific omics data modalities
      ├─ AI model architectures  
      ├─ Interpretability frameworks
      ├─ Clinical implications
      └─ Translational potential

QUALITY ASSURANCE:
├─ PRISMA 2020 guidelines followed
├─ Bias minimization through dual review
├─ Systematic exclusion criteria application
└─ Reproducible methodology documentation

STUDY CHARACTERISTICS (n = 88):
├─ Publication years: 2019-2025
├─ Focus: GNNs, RNNs, attention mechanisms + spatial omics
├─ Application: Cardiomyocyte differentiation & cardiac regeneration
└─ Data extraction: Methodological and translational insights
